Although the PIONEER and SUSTAIN studies only examined serious adverse reactions (SAEs) for people taking semaglutide, it is possible that similar reactions could occur after taking other GLP-1 drugs
The article ties tirzepatide, cost and coverage, side effects, provider access back to comparison and decision support
The role of oxidative stress in diabetic vascular and neural disease
The difference between a plateau and loss of effect Weight loss is rarely linear
Considering the strength of current evidence alongside the risk profile for different agents is key to informing the direction of future research
Yen, F.-S., Wang, S.-I., Hsu, C.-C., Hwu, C.-M